KLP Kapitalforvaltning’s Avidity Biosciences RNAM Stock Holding History

KLP Kapitalforvaltning’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,300	Closed	-$1.68M	–	2192
2025 Q4	$1.68M	Hold	23,300	–	–	0.01%	785
2025 Q3	$1.02M	Buy	23,300 +4,300	+23%	+$174K	﹤0.01%	1020
2025 Q2	$540K	Buy	19,000 +3,100	+19%	+$92.4K	﹤0.01%	1336
2025 Q1	$469K	Sell	15,900 -2,000	-11%	-$62.3K	﹤0.01%	1333
2024 Q4	$521K	Buy	+17,900	New	+$748K	﹤0.01%	1357

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

KLP Kapitalforvaltning's RNAM Position: Q1 2026 in Review

KLP Kapitalforvaltning sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 23,300 shares — an estimated $1.68M sold.

KLP Kapitalforvaltning first reported a position in RNAM in Q4 2024 and held it in 5 quarters. The position peaked at $1.68M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

KLP Kapitalforvaltning reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
KLP Kapitalforvaltning sold 23,300 Avidity Biosciences shares in Q1 2026, an estimated $1.68M.
KLP Kapitalforvaltning first reported a position in Avidity Biosciences in Q4 2024 and held it in 5 quarters.
KLP Kapitalforvaltning's Avidity Biosciences position peaked at $1.68M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.